Real-Time Breast Cancer Surgery

This is a news story, published by MIT News, that relates primarily to Lumicell news.

Lumicell news

For more Lumicell news, you can click here:

more Lumicell news

medical innovations news

For more medical innovations news, you can click here:

more medical innovations news

MIT News news

For more news from MIT News, you can click here:

more news from MIT News

About the Otherweb

Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like medical innovations news, you might also like this article about

care lumpectomy

. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest cancer detection software news, Breast cancer news, medical innovations news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!

lumpectomy surgery

MIT News

•

Startup gives surgeons a real-time view of breast cancer during surgery

Summary

Nutrition label

81% Informative

MIT spinout Lumicell has developed a handheld device and optical imaging agent that allows surgeons to scan the tissue within the surgical cavity to visualize residual cancer cells.

The surgeons see these images on a monitor that can guide them to remove additional tissue during the procedure.

The company received U.S. Food and Drug Administration approval for the technology earlier this year .

Lumicell ’s cancer detection software shows spots that highlight regions suspected to contain residual cancer on the computer monitor, which the surgeon can then remove.

The process adds less than 7 minutes on average to the procedure.

The company is exploring if its imaging agent is activated in other tumor types, including prostate, sarcoma, esophageal, gastric , and more.

VR Score

Informative language

Neutral language

Article tone

formal

Language

English

Language complexity

Offensive language

not offensive